Press release
Global Organoids And Spheroids Market Projected to Surpass $3.46 Billion by 2029 with 24.4% Annual Growth
Organoids And Spheroids
The increasing demand for cell therapy and tissue engineering is expected to boost the organoids and spheroids market. Cell therapy and tissue engineering offer innovative treatments for regenerating damaged tissues and organs, driving demand in regenerative medicine. Organoids and spheroids are used to model complex tissues for therapeutic testing. According to Cell & Gene, the FDA approved 27 cell and gene therapies in 2022, up from 22 in 2021. This demand for regenerative treatments is fueling the growth of the organoids and spheroids market.
Get Your Organoids And Spheroids Market Report Here:
https://www.thebusinessresearchcompany.com/report/organoids-and-spheroids-global-market-report
What is the projected compound annual growth rate (CAGR) of the organoids and spheroids market from 2025 to 2034, and what factors influence it?
The organoids and spheroids market has experienced exponential growth, increasing from $1.16 billion in 2024 to $1.45 billion in 2025 at a CAGR of 24.6%. Growth drivers include rapid advances in stem cell research and 3D cell culture, increased R&D funding, rising chronic disease prevalence, expanding applications in drug screening and regenerative medicine, and supportive regulatory frameworks.
The organoids and spheroids market is projected to grow exponentially, reaching $3.46 billion in 2029 at a CAGR of 24.4%. This growth will be fueled by technological advancements, the expansion of personalized medicine, applications in cancer research, and increased commercialization of organoid-based services. Major trends include integration with advanced technologies, high-throughput drug screening, 3D bioprinting, cancer modeling, and the use of microfluidic systems.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18421&type=smp
How are the latest trends influencing the growth of the organoids and spheroids market?
Companies in the organoids and spheroids market are developing advanced solutions like single-particle dispensers to improve precision in cell handling and enhance reproducibility in research. Single-particle dispensers are designed to isolate and dispense individual cells or particles accurately in research applications. For example, in July 2024, SEED Biosciences, a Switzerland-based biotechnology company, introduced Dispen3D, a tool for accurately dispensing spheroids and organoids. This device ensures monoclonality in drug discovery and customized treatments by precisely transferring individual cells into multi-well plates.
What are the major segments of the organoids and spheroids market and their role in driving growth?
The organoids and spheroids market covered in this report is segmented -
1) By Type: Organoids, Spheroids
2) By Method: Extracellular Matrix Scaffold Method, Spinning Bioreactor Method, Hanging Drop Method, Low Adherent Culture Plate Method, Magnetic levitation Method, Other Methods
3) By Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity And Efficacy Testing
4) By End User: Biotechnology And Pharmaceutical Industry, Academic And Research Institutes, Hospitals And Diagnostic Centers
Subsegments:
1) By Organoids: Intestinal Organoids, Liver Organoids, Brain Organoids, Kidney Organoids, Lung Organoids, Pancreatic Organoids, Cardiac Organoids, Retinal Organoids, Tumor Organoids, Organoids For Disease Modeling
2) By Spheroids: Cancer Spheroids, Neural Spheroids, Cardiac Spheroids, Liver Spheroids, Muscle Spheroids, Endothelial Spheroids, Stem Cell-Derived Spheroids, 3D Cell Culture Spheroids
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18421
Which region dominates the organoids and spheroids market?
North America was the largest region in the organoids and spheroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoids and spheroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the organoids and spheroids market?
Major companies operating in the organoids and spheroids market are Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, StemCell Technologies Canada Inc., Greiner Bio-One International AG, Promega Corporation, Molecular Devices LLC, American Type Culture Collection (ATCC), Mimetas B.V., InSphero AG, HUB Organoids, Emulate Inc., 3D Biomatrix Inc., Prellis Biologics Inc., 3D Biotek LLC, DefiniGEN Limited, Visikol Inc., Organovo Holdings Inc., Cellesce Ltd., AMS Biotechnology (Europe) Limited
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=18421&type=smp
What Is Covered In The Organoids And Spheroids Global Market Report?
•Market Size Forecast: Examine the organoids and spheroids market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the organoids and spheroids market for a structured understanding.
•Key Players Overview: Analyze major players in the organoids and spheroids market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the organoids and spheroids market.
•Segment Contributions: Evaluate how different segments drive overall growth in the organoids and spheroids market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the organoids and spheroids market.
•Industry Challenges: Identify potential risks and obstacles affecting the organoids and spheroids market.
•Competitive Landscape: Review strategic developments in the organoids and spheroids market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Organoids And Spheroids Market Projected to Surpass $3.46 Billion by 2029 with 24.4% Annual Growth here
News-ID: 3928375 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Organoids
Biocomputer Based on Organoids Market Poised for 16.3% CAGR Driven by Brain Orga …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biocomputer Based on Organoids Market Size, Share & Trends Analysis Report By Organoid Type (Brain Organoids, Other Organoids), Application (Biological Computing, Neuroscience Research, Drug Discovery and Testing, Personalized Medicine, Regenerative Medicine), Technology (Microfluidic Systems Microelectrode Arrays (MEAs), Brain-Machine Interfaces, CRISPR and Gene Editing), End-User (Academic and Research Institutes, Biotechnology and Pharmaceutical Companies, Technology Companies, Contract…
Organoids: A Guide to Understanding the Process
Organoids are emerging as a powerful asset for researchers and drug developers as they seek more efficient and accurate methods to identify promising drug candidates and predict their efficacy. The ability to generate patient-derived organoids (PDOs) opens up exciting possibilities for personalized drug screening. Organoids serve as realistic and relevant models for drug screening compared to traditional 2D cell cultures. They mimic the complexity of human organs, including their cellular…
Patient-derived organoids open doors to personalized medicine
Recent advances in organoid technology have opened the possibility of revolutionizing basic research, drug discovery and development, and patient treatment.
Scientists are exploring the feasibility of using patient-derived organoids (PDOs) to develop and test personalized and regenerative medicine for certain cancer subtypes. Although this shows promise, broad adoption of organoids in drug discovery studies still faces many challenges, such as inconsistent quality, poor yield, slow data acquisition, and inaccurate data processing.
We…
Organoids Market - Pioneering Solutions for Personalized Medicine: Organoids Sha …
Newark, New Castle, USA - new report, titled Organoids Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Organoids market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Organoids market. The report offers an overview of the market, which briefly describes the…
Organoids and Spheroids Market Emerging Trends 2023-2030
The worldwide organoids and spheroids market size was estimated at USD 405.3 million in 2021 and is supposed to develop yearly from 2022 to 2028. Utilization of the organoids and spheroids models to uncover what the COVID-19 infection means for a few digestive cells is supposed to drive the reception of organoids in research. Researchers have been involving these frameworks for testing and recognizable proof of promising prescriptions. Organizations take…
Sweden Organoids Market Scrutinized in New Research 2030
Organoids Market: Introduction
According to the report, the global organoids market was valued over US$ 1.7 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030. Organoids are replicated or miniaturized versions of organs such as stomach, liver, lung, kidney, and brain produced from stems cells in vitro. These miniature models are three-dimensional tissue culture derived from stem cells. The stem cells are derived from pluripotent and…
